Welcome to SELECTBIO

SELECTBIO provides focused market reports, custom consultancy, recruitment, training courses and conferences to the life science marketplace. Specialising in early stage drug discovery and omics, we provide open forums for learning and networking, with the aim of fostering discussion and debate to advance disease research.

Conferences	Business Courses	Training Courses

Our specialist portfolio of global life science events provide attendees with a rich learning and networking environment where they can share and discuss the latest developments in their field. Ideal for professionals working in industry and academic settings within life science.	SELECTBIO business courses provide attendees with an up-to-date analysis of the life sciences, diagnostics and pharma-discovery space. Ideal for people involved in business planning processes and for those wishing to research and understand new market opportunities.	Keep up to date with emerging research techniques, technology developments and regulatory changes by attending one of our short courses or workshops.

Customer Testimonials

"A great focussed meeting, with attendees interested in our products. Very well organised at registration and during the course of the meeting, professional, helpful and friendly staff across the board."	"Good range of speakers and topics"	"I would like to say thank you for giving me an opportunity to participate in the European Lab Automation Congress. It was a pleasure to present my work; I also have met my old friends there and created new interesting contacts; got lots of ideas for my research."
European Lab Automation	Stem Cells	European Lab Automation
TAP Biosystems	ITI Life Sciences	Natalie Kostesha, Technical University of Denmark

Conference News

Trends at the forefront of liquid handling and lab automation
This week we caught up with Joe Liscouski, Executive Director at the Institute for Laboratory Automation (ILA) in MA, USA, to find out more about how the use of liquid handling has evolved over the last decade and to gain some insight into what we can expect next.

The ethics around biobanking – an interview with Zubin Master
This week’s blog focusses on the ethical issues surrounding biobanking, based on a recent interview we conducted with Zubin Master. Dr Master, Assistant Professor at the Alden March Bioethics Institute of Albany Medical College, will be discussing this topic in detail at ELA 2013 as part of his presentation, “Biobanks: Consent, Consensus & Public Trust.”

Standards Make High-Content Screening Data More Powerful.....An Interview with Dr Stephan Schürer
Dr Stephan Schürer from the University of Miami speaks about the goals of the BioAssay Ontology Project to enable standardized description, integration and meta-analysis of assay and screening results - http://bit.ly/15HpwvN Dr Schürer will be discussing this topic in more detail at ELA 2013 as part of the Drug Discovery Automation track - http://bit.ly/16jbuPq

Harnessing the Great Promise of Microfluidics - an interview with Holger Becker
Dr Holger Becker, Chief Scientific Officer of microfluidic ChipShop GmbH, discusses the great potential of microfluidics in our latest blog entry – http://bit.ly/15HpwvN. Dr Becker will also be running a training course on ‘Microfluidics from the Concept to a Product: Technologies, Applications and Commercialisation Strategies’ at ELA on June 5th http://bit.ly/13ovJPE

New ELA Blog
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f . We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!

Optimising NGS workflows – an interview with Dr Mike Quail, Team Leader at the Sanger Institute
In this week's blog entry - http://bit.ly/15HpwvN - Dr Quail gives us some insight into the current advances being made in NGS, as well as some of the challenges still facing the optimisation of NGS pipelines. Dr Quail will be speaking at ELA 2013 about the new NGS applications being developed at the Sanger Institute, as well as some of improvements his team are making to sequencing protocols.